Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
CALGARY, June 5, 2017 /CNW/ - Zenith Capital Corp. ("Zenith" or the "Company") announced that a patent covering its clinical compound, ZEN-3694, has been issued by the United States Patent and...
CALGARY, Jan. 5, 2017 /CNW/ - Zenith Capital Corp. ("Zenith" or the "Company") today announces its participation in the upcoming 9th Annual Biotech Showcase Conference during J.P. Morgan week in San...
CALGARY, Dec. 14, 2016 /CNW/ - Zenith Capital Corp. ("Zenith" or the "Company") today announced that its wholly owned subsidiary, Zenith Epigenetics Ltd. ("Zenith Epigenetics"), has initiated a Phase ...
CALGARY, Dec. 7, 2016 /CNW/ - Zenith Capital Corp. ("Zenith" or the "Company") announces webcast details for a corporate update that will be presented at the Company's Annual and Special Meeting. The ...
CALGARY, Aug. 2, 2016 /CNW/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") announced today that it has changed its name to Zenith Capital Corp. concurrent with the internal corporate...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.